CV1002: SARS-CoV-1 Nucleocapsid Protein

LifeSensors CV1002 offers advanced ubiquitin proteasome research tools, enabling precise E2 enzyme identification and ubiquitin chain analysis for drug discovery.

$1,025.00

SKU CV-1002-0100 Categories DUBs, Viral and Bacterial DUBs

In stock

Product Advantages

Applications

Background

Within the last two decades, SARS and MERS coronaviruses emerged as global health concerns causing severe acute respiratory syndromes. In December 2019, a novel coronavirus (SARS-CoV-2) was identified in Wuhan, Hubei province in China. The SARS-CoV genome encodes several structural proteins including the nucleocapsid protein (Nucleoprotein; Protein N), which plays a role in virion assembly through its interaction with the viral genome and the membrane protein. This key viral protein plays an RNA chaperone role. SARS-CoV nucleocapsid protein shares a 90% protein sequence identity with the nucleocapsid protein from SARS-CoV-2. The nucleocapsid represents a valuable tool for diagnostic and vaccine production purposes.

Info

Species	SARS-CoV
Source	E. coli
Tag	None
Molecular Weight	46 kDa
Quantity	100 µg
Concentration	Variable
Formulation
Storage	-80^o C. Avoid repeated freeze/thaw cycles.